Loading…
The outcomes of cataract surgery in eyes with Fuchs uveitis
Background To evaluate clinical results in eyes undergoing phacoemulsification intraocular lens (IOL) implantation due to Fuchs , uveitis (FU) related complicated cataract. Methods Post-surgical outcomes of 56 eyes of 55 FU patients were evaluated retrospectively. Three groups were formed according...
Saved in:
Published in: | Journal of ophthalmic inflammation and infection 2023-02, Vol.13 (1), p.4-4, Article 4 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c421t-5bc922cece828e48152a8fbf5939906503928702cb8ae9606ceea8827d7e3e353 |
container_end_page | 4 |
container_issue | 1 |
container_start_page | 4 |
container_title | Journal of ophthalmic inflammation and infection |
container_volume | 13 |
creator | Özdamar Erol, Yasemin Özdemir Yalçınsoy, Kübra Özdal, Pınar |
description | Background
To evaluate clinical results in eyes undergoing phacoemulsification intraocular lens (IOL) implantation due to Fuchs
,
uveitis (FU) related complicated cataract.
Methods
Post-surgical outcomes of 56 eyes of 55 FU patients were evaluated retrospectively. Three groups were formed according to the IOL model: hydrophilic SAF6125 (Optima fold) acrylic, hydrophobic SN60AT (Alcon), and hydrophobic AAB00 (Abbott). Postoperative posterior capsular opacification (PCO) development and PCO development time, neodymium number: YAG laser posterior capsulotomy rate, giant cell (GC) deposition on the IOL, and the development time of GC deposits were compared among the groups. All patients were followed postoperatively on the 1
st
day, 1
st
week, 2
nd
and 6
th
weeks, and then at 3-month intervals.
Results
The hydrophilic SAF6125 IOL was implanted in 10 eyes, hydrophobic SN60AT in 24 eyes and AAB00 IOL in 22 eyes. The mean postoperative follow-up time was 34.1 ± 30.1 (6-144) months. PCO developed in 7 eyes (70%) in the hydrophilic SAF6125 group, 17 eyes (70.8%) in the hydrophobic SN60AT and 13 eyes (59.1%) in the AAB00 group. There was no statistically significant difference among the three IOL groups in the PCO development, the PCO development time and YAG laser capsulotomy rates (
P
= 0.674,
P
= 0.111, and
P
= 0.507, respectively). The PCO development time was significantly longer in the hydrophobic SN60AT than AAB00 group (
P
= 0.027). GC deposits were detected in 3 eyes (30%) in the hydrophilic SAF6125 group, 7 eyes (29.1%) in the hydrophobic SN60AT and 3 eyes (13.6%) in the AAB00 group. GC deposition and the development time of GC deposits were similar among the three IOL groups (
P
= 0.575,
P
= 0.804). At the final follow-up, BCVA was ≥ 20/40 in 41 eyes (73.2%).
Conclusion
The GC deposits and PCO development were the most important problems in these eyes with hydrophilic or hydrophobic IOLs despite good visual and postoperative results. New developments are needed in terms of IOL design or content in eyes with FU. |
doi_str_mv | 10.1186/s12348-022-00320-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7030487b6a7d4c559eb5fe3a71b893e7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7030487b6a7d4c559eb5fe3a71b893e7</doaj_id><sourcerecordid>2775863962</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-5bc922cece828e48152a8fbf5939906503928702cb8ae9606ceea8827d7e3e353</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYMotqz9Aj7IgC--jCY3k38IghSrhYIv9Tlksnd2s8xOapKp7Lc33am19cG8JOSce-5NfoS8ZvQ9Y1p-yAx4p1sK0FLKgbb8GTmtgmmFkvT5o_MJOct5R-vqJDChX5ITLpWmtfSUfLzeYhPn4uMecxOHxrvikvOlyXPaYDo0YWrwULVfoWybi9lvczPfYighvyIvBjdmPLvfV-THxZfr82_t1fevl-efr1rfASut6L0B8OhRg8ZOMwFOD_0gDDeGSkG5Aa0o-F47NJJKj-i0BrVWyJELviKXS-46up29SWHv0sFGF-zxIqaNdakEP6JVlNNOq146te68EAZ7MSB3ivXacFQ169OSdTP3e1x7nEpy45PQp8oUtnYTb60xIGQdeUXe3Qek-HPGXOw-ZI_j6CaMc7aglDCCVybV-vYf6y7OaapfdXRpyY2E6oLF5VPMOeHwMAyj9g61XVDbysseUdu76DePn_FQ8gdsNfDFkKs0VZB_e_8n9jdLfbKO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2775863962</pqid></control><display><type>article</type><title>The outcomes of cataract surgery in eyes with Fuchs uveitis</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><creator>Özdamar Erol, Yasemin ; Özdemir Yalçınsoy, Kübra ; Özdal, Pınar</creator><creatorcontrib>Özdamar Erol, Yasemin ; Özdemir Yalçınsoy, Kübra ; Özdal, Pınar</creatorcontrib><description>Background
To evaluate clinical results in eyes undergoing phacoemulsification intraocular lens (IOL) implantation due to Fuchs
,
uveitis (FU) related complicated cataract.
Methods
Post-surgical outcomes of 56 eyes of 55 FU patients were evaluated retrospectively. Three groups were formed according to the IOL model: hydrophilic SAF6125 (Optima fold) acrylic, hydrophobic SN60AT (Alcon), and hydrophobic AAB00 (Abbott). Postoperative posterior capsular opacification (PCO) development and PCO development time, neodymium number: YAG laser posterior capsulotomy rate, giant cell (GC) deposition on the IOL, and the development time of GC deposits were compared among the groups. All patients were followed postoperatively on the 1
st
day, 1
st
week, 2
nd
and 6
th
weeks, and then at 3-month intervals.
Results
The hydrophilic SAF6125 IOL was implanted in 10 eyes, hydrophobic SN60AT in 24 eyes and AAB00 IOL in 22 eyes. The mean postoperative follow-up time was 34.1 ± 30.1 (6-144) months. PCO developed in 7 eyes (70%) in the hydrophilic SAF6125 group, 17 eyes (70.8%) in the hydrophobic SN60AT and 13 eyes (59.1%) in the AAB00 group. There was no statistically significant difference among the three IOL groups in the PCO development, the PCO development time and YAG laser capsulotomy rates (
P
= 0.674,
P
= 0.111, and
P
= 0.507, respectively). The PCO development time was significantly longer in the hydrophobic SN60AT than AAB00 group (
P
= 0.027). GC deposits were detected in 3 eyes (30%) in the hydrophilic SAF6125 group, 7 eyes (29.1%) in the hydrophobic SN60AT and 3 eyes (13.6%) in the AAB00 group. GC deposition and the development time of GC deposits were similar among the three IOL groups (
P
= 0.575,
P
= 0.804). At the final follow-up, BCVA was ≥ 20/40 in 41 eyes (73.2%).
Conclusion
The GC deposits and PCO development were the most important problems in these eyes with hydrophilic or hydrophobic IOLs despite good visual and postoperative results. New developments are needed in terms of IOL design or content in eyes with FU.</description><identifier>ISSN: 1869-5760</identifier><identifier>EISSN: 1869-5760</identifier><identifier>DOI: 10.1186/s12348-022-00320-3</identifier><identifier>PMID: 36780022</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biocompatibility ; Cataract ; Cataracts ; Cornea ; Diabetic retinopathy ; Edema ; Eye surgery ; Fuchs’ Uveitis ; Hospitals ; Infections ; Inflammation ; Intraocular lenses ; Lasers ; Medicine ; Medicine & Public Health ; Open access publishing ; Ophthalmology ; Phacoemulsification ; Steroids ; Surgical outcomes</subject><ispartof>Journal of ophthalmic inflammation and infection, 2023-02, Vol.13 (1), p.4-4, Article 4</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c421t-5bc922cece828e48152a8fbf5939906503928702cb8ae9606ceea8827d7e3e353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2775863962/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2775863962?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36780022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özdamar Erol, Yasemin</creatorcontrib><creatorcontrib>Özdemir Yalçınsoy, Kübra</creatorcontrib><creatorcontrib>Özdal, Pınar</creatorcontrib><title>The outcomes of cataract surgery in eyes with Fuchs uveitis</title><title>Journal of ophthalmic inflammation and infection</title><addtitle>J Ophthal Inflamm Infect</addtitle><addtitle>J Ophthalmic Inflamm Infect</addtitle><description>Background
To evaluate clinical results in eyes undergoing phacoemulsification intraocular lens (IOL) implantation due to Fuchs
,
uveitis (FU) related complicated cataract.
Methods
Post-surgical outcomes of 56 eyes of 55 FU patients were evaluated retrospectively. Three groups were formed according to the IOL model: hydrophilic SAF6125 (Optima fold) acrylic, hydrophobic SN60AT (Alcon), and hydrophobic AAB00 (Abbott). Postoperative posterior capsular opacification (PCO) development and PCO development time, neodymium number: YAG laser posterior capsulotomy rate, giant cell (GC) deposition on the IOL, and the development time of GC deposits were compared among the groups. All patients were followed postoperatively on the 1
st
day, 1
st
week, 2
nd
and 6
th
weeks, and then at 3-month intervals.
Results
The hydrophilic SAF6125 IOL was implanted in 10 eyes, hydrophobic SN60AT in 24 eyes and AAB00 IOL in 22 eyes. The mean postoperative follow-up time was 34.1 ± 30.1 (6-144) months. PCO developed in 7 eyes (70%) in the hydrophilic SAF6125 group, 17 eyes (70.8%) in the hydrophobic SN60AT and 13 eyes (59.1%) in the AAB00 group. There was no statistically significant difference among the three IOL groups in the PCO development, the PCO development time and YAG laser capsulotomy rates (
P
= 0.674,
P
= 0.111, and
P
= 0.507, respectively). The PCO development time was significantly longer in the hydrophobic SN60AT than AAB00 group (
P
= 0.027). GC deposits were detected in 3 eyes (30%) in the hydrophilic SAF6125 group, 7 eyes (29.1%) in the hydrophobic SN60AT and 3 eyes (13.6%) in the AAB00 group. GC deposition and the development time of GC deposits were similar among the three IOL groups (
P
= 0.575,
P
= 0.804). At the final follow-up, BCVA was ≥ 20/40 in 41 eyes (73.2%).
Conclusion
The GC deposits and PCO development were the most important problems in these eyes with hydrophilic or hydrophobic IOLs despite good visual and postoperative results. New developments are needed in terms of IOL design or content in eyes with FU.</description><subject>Biocompatibility</subject><subject>Cataract</subject><subject>Cataracts</subject><subject>Cornea</subject><subject>Diabetic retinopathy</subject><subject>Edema</subject><subject>Eye surgery</subject><subject>Fuchs’ Uveitis</subject><subject>Hospitals</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Intraocular lenses</subject><subject>Lasers</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Open access publishing</subject><subject>Ophthalmology</subject><subject>Phacoemulsification</subject><subject>Steroids</subject><subject>Surgical outcomes</subject><issn>1869-5760</issn><issn>1869-5760</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kV9rFDEUxYMotqz9Aj7IgC--jCY3k38IghSrhYIv9Tlksnd2s8xOapKp7Lc33am19cG8JOSce-5NfoS8ZvQ9Y1p-yAx4p1sK0FLKgbb8GTmtgmmFkvT5o_MJOct5R-vqJDChX5ITLpWmtfSUfLzeYhPn4uMecxOHxrvikvOlyXPaYDo0YWrwULVfoWybi9lvczPfYighvyIvBjdmPLvfV-THxZfr82_t1fevl-efr1rfASut6L0B8OhRg8ZOMwFOD_0gDDeGSkG5Aa0o-F47NJJKj-i0BrVWyJELviKXS-46up29SWHv0sFGF-zxIqaNdakEP6JVlNNOq146te68EAZ7MSB3ivXacFQ169OSdTP3e1x7nEpy45PQp8oUtnYTb60xIGQdeUXe3Qek-HPGXOw-ZI_j6CaMc7aglDCCVybV-vYf6y7OaapfdXRpyY2E6oLF5VPMOeHwMAyj9g61XVDbysseUdu76DePn_FQ8gdsNfDFkKs0VZB_e_8n9jdLfbKO</recordid><startdate>20230213</startdate><enddate>20230213</enddate><creator>Özdamar Erol, Yasemin</creator><creator>Özdemir Yalçınsoy, Kübra</creator><creator>Özdal, Pınar</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><general>SpringerOpen</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230213</creationdate><title>The outcomes of cataract surgery in eyes with Fuchs uveitis</title><author>Özdamar Erol, Yasemin ; Özdemir Yalçınsoy, Kübra ; Özdal, Pınar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-5bc922cece828e48152a8fbf5939906503928702cb8ae9606ceea8827d7e3e353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biocompatibility</topic><topic>Cataract</topic><topic>Cataracts</topic><topic>Cornea</topic><topic>Diabetic retinopathy</topic><topic>Edema</topic><topic>Eye surgery</topic><topic>Fuchs’ Uveitis</topic><topic>Hospitals</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Intraocular lenses</topic><topic>Lasers</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Open access publishing</topic><topic>Ophthalmology</topic><topic>Phacoemulsification</topic><topic>Steroids</topic><topic>Surgical outcomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özdamar Erol, Yasemin</creatorcontrib><creatorcontrib>Özdemir Yalçınsoy, Kübra</creatorcontrib><creatorcontrib>Özdal, Pınar</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of ophthalmic inflammation and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özdamar Erol, Yasemin</au><au>Özdemir Yalçınsoy, Kübra</au><au>Özdal, Pınar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The outcomes of cataract surgery in eyes with Fuchs uveitis</atitle><jtitle>Journal of ophthalmic inflammation and infection</jtitle><stitle>J Ophthal Inflamm Infect</stitle><addtitle>J Ophthalmic Inflamm Infect</addtitle><date>2023-02-13</date><risdate>2023</risdate><volume>13</volume><issue>1</issue><spage>4</spage><epage>4</epage><pages>4-4</pages><artnum>4</artnum><issn>1869-5760</issn><eissn>1869-5760</eissn><abstract>Background
To evaluate clinical results in eyes undergoing phacoemulsification intraocular lens (IOL) implantation due to Fuchs
,
uveitis (FU) related complicated cataract.
Methods
Post-surgical outcomes of 56 eyes of 55 FU patients were evaluated retrospectively. Three groups were formed according to the IOL model: hydrophilic SAF6125 (Optima fold) acrylic, hydrophobic SN60AT (Alcon), and hydrophobic AAB00 (Abbott). Postoperative posterior capsular opacification (PCO) development and PCO development time, neodymium number: YAG laser posterior capsulotomy rate, giant cell (GC) deposition on the IOL, and the development time of GC deposits were compared among the groups. All patients were followed postoperatively on the 1
st
day, 1
st
week, 2
nd
and 6
th
weeks, and then at 3-month intervals.
Results
The hydrophilic SAF6125 IOL was implanted in 10 eyes, hydrophobic SN60AT in 24 eyes and AAB00 IOL in 22 eyes. The mean postoperative follow-up time was 34.1 ± 30.1 (6-144) months. PCO developed in 7 eyes (70%) in the hydrophilic SAF6125 group, 17 eyes (70.8%) in the hydrophobic SN60AT and 13 eyes (59.1%) in the AAB00 group. There was no statistically significant difference among the three IOL groups in the PCO development, the PCO development time and YAG laser capsulotomy rates (
P
= 0.674,
P
= 0.111, and
P
= 0.507, respectively). The PCO development time was significantly longer in the hydrophobic SN60AT than AAB00 group (
P
= 0.027). GC deposits were detected in 3 eyes (30%) in the hydrophilic SAF6125 group, 7 eyes (29.1%) in the hydrophobic SN60AT and 3 eyes (13.6%) in the AAB00 group. GC deposition and the development time of GC deposits were similar among the three IOL groups (
P
= 0.575,
P
= 0.804). At the final follow-up, BCVA was ≥ 20/40 in 41 eyes (73.2%).
Conclusion
The GC deposits and PCO development were the most important problems in these eyes with hydrophilic or hydrophobic IOLs despite good visual and postoperative results. New developments are needed in terms of IOL design or content in eyes with FU.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>36780022</pmid><doi>10.1186/s12348-022-00320-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1869-5760 |
ispartof | Journal of ophthalmic inflammation and infection, 2023-02, Vol.13 (1), p.4-4, Article 4 |
issn | 1869-5760 1869-5760 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_7030487b6a7d4c559eb5fe3a71b893e7 |
source | PubMed Central Free; Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access |
subjects | Biocompatibility Cataract Cataracts Cornea Diabetic retinopathy Edema Eye surgery Fuchs’ Uveitis Hospitals Infections Inflammation Intraocular lenses Lasers Medicine Medicine & Public Health Open access publishing Ophthalmology Phacoemulsification Steroids Surgical outcomes |
title | The outcomes of cataract surgery in eyes with Fuchs uveitis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A08%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20outcomes%20of%20cataract%20surgery%20in%20eyes%20with%20Fuchs%20uveitis&rft.jtitle=Journal%20of%20ophthalmic%20inflammation%20and%20infection&rft.au=%C3%96zdamar%20Erol,%20Yasemin&rft.date=2023-02-13&rft.volume=13&rft.issue=1&rft.spage=4&rft.epage=4&rft.pages=4-4&rft.artnum=4&rft.issn=1869-5760&rft.eissn=1869-5760&rft_id=info:doi/10.1186/s12348-022-00320-3&rft_dat=%3Cproquest_doaj_%3E2775863962%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-5bc922cece828e48152a8fbf5939906503928702cb8ae9606ceea8827d7e3e353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2775863962&rft_id=info:pmid/36780022&rfr_iscdi=true |